Ambroxol for Parkinson's Disease

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2026-02-24
DOI
https://doi.org/10.1002/mds.70242
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ambroxol for Parkinson's Disease

Marco Toffoli, Elisa Menozzi, Tom Foltynie, Kashfia Chowdhury et al.
Movement Disorders
Parkinson's Disease Mechanisms and Treatments
article

Ambroxol for Parkinson's Disease

Marco Toffoli, Elisa Menozzi, Tom Foltynie, Kashfia Chowdhury, Olivier Rascol, Werner Poewe, Anthony Schapira
article en

Abstract

No abstract available for this paper.
Movement Disorders
Innsbruck Medical University (AT), Inserm (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), University of Rochester Medical Center (US), MRC Clinical Trials Unit at UCL (GB), Centre for Movement Disorders (CA), National Hospital for Neurology and Neurosurgery (GB), Research Network (United States) (US), Comprehensive Clinical Trials (US), French Clinical Research Infrastructure Network (FR), University College London (GB)
Openalex Percentile: Top 48%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.